| 产品名称: | Human rhinovirus 50 |
|---|---|
| 商品货号: | TS213780 |
| Classification: | Picornaviridae, Enterovirus, Human rhinovirus A |
| Deposited As: | Rhinovirus 50 |
| Agent: | Human rhinovirus 50 |
| Strain: | A2#58 |
| Applications: | Respiratory research |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | frozen 1.0 mL per vial |
| Storage Conditions: | -70°C or colder |
| Images: | |
| Comments: | ATCC® VR-1876™ was derived from ATCC® VR-517™ following treatment with diethyl ether to remove mycoplasma contamination. |
| Effect on Host: | CPE, refractile rounding and sloughing |
| Recommended Host: | HeLa cells (ATCC® CCL-2™) |
| Growth Conditions: | Temperature: 33°C Recommendations for Infection: Plate cells 18-24 hours prior to infection and infect when cultures are 70-80% confluent. Remove medium and inoculate with a small volume of virus (e.g. 1 mL per 25 cm2) diluted to provide an optimal MOI (e.g. 0.1). Adsorb 1.5-2.0 hours at 33°C in a humidified 5% CO2 atmosphere while rocking. End adsorption by adding virus growth medium. Incubation: 6-7 days at 33°C in a humidified 5% CO2 atmosphere, until CPE is progressed through 80% of the monolayer. |
| Name of Depositor: | VV Hamparian, RM Conant |
| Chain of Custody: | ATCC |
| Source: | Human throat washings |